Global Eosinophilic Esophagitis Drug Market Insights and Forecast to 2028

Report ID: 1230042 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Eosinophilic Esophagitis Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Budesonide
        1.2.3 Fluticasone
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Drugstore
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Eosinophilic Esophagitis Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Eosinophilic Esophagitis Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Eosinophilic Esophagitis Drug Sales by Region
        2.4.1 Global Eosinophilic Esophagitis Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Eosinophilic Esophagitis Drug by Region (2023-2028)
    2.5 Global Eosinophilic Esophagitis Drug Revenue by Region
        2.5.1 Global Eosinophilic Esophagitis Drug Revenue by Region (2017-2022)
        2.5.2 Global Eosinophilic Esophagitis Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturers
        3.1.1 Global Top Eosinophilic Esophagitis Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Eosinophilic Esophagitis Drug in 2021
    3.2 Global Eosinophilic Esophagitis Drug Revenue by Manufacturers
        3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Eosinophilic Esophagitis Drug Revenue in 2021
    3.3 Global Eosinophilic Esophagitis Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Eosinophilic Esophagitis Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Eosinophilic Esophagitis Drug Sales by Type
        4.1.1 Global Eosinophilic Esophagitis Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Eosinophilic Esophagitis Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2017-2028)
    4.2 Global Eosinophilic Esophagitis Drug Revenue by Type
        4.2.1 Global Eosinophilic Esophagitis Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Eosinophilic Esophagitis Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Eosinophilic Esophagitis Drug Price by Type
        4.3.1 Global Eosinophilic Esophagitis Drug Price by Type (2017-2022)
        4.3.2 Global Eosinophilic Esophagitis Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Eosinophilic Esophagitis Drug Sales by Application
        5.1.1 Global Eosinophilic Esophagitis Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Eosinophilic Esophagitis Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2017-2028)
    5.2 Global Eosinophilic Esophagitis Drug Revenue by Application
        5.2.1 Global Eosinophilic Esophagitis Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Eosinophilic Esophagitis Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Eosinophilic Esophagitis Drug Price by Application
        5.3.1 Global Eosinophilic Esophagitis Drug Price by Application (2017-2022)
        5.3.2 Global Eosinophilic Esophagitis Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Eosinophilic Esophagitis Drug Market Size by Type
        6.1.1 North America Eosinophilic Esophagitis Drug Sales by Type (2017-2028)
        6.1.2 North America Eosinophilic Esophagitis Drug Revenue by Type (2017-2028)
    6.2 North America Eosinophilic Esophagitis Drug Market Size by Application
        6.2.1 North America Eosinophilic Esophagitis Drug Sales by Application (2017-2028)
        6.2.2 North America Eosinophilic Esophagitis Drug Revenue by Application (2017-2028)
    6.3 North America Eosinophilic Esophagitis Drug Market Size by Country
        6.3.1 North America Eosinophilic Esophagitis Drug Sales by Country (2017-2028)
        6.3.2 North America Eosinophilic Esophagitis Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Eosinophilic Esophagitis Drug Market Size by Type
        7.1.1 Europe Eosinophilic Esophagitis Drug Sales by Type (2017-2028)
        7.1.2 Europe Eosinophilic Esophagitis Drug Revenue by Type (2017-2028)
    7.2 Europe Eosinophilic Esophagitis Drug Market Size by Application
        7.2.1 Europe Eosinophilic Esophagitis Drug Sales by Application (2017-2028)
        7.2.2 Europe Eosinophilic Esophagitis Drug Revenue by Application (2017-2028)
    7.3 Europe Eosinophilic Esophagitis Drug Market Size by Country
        7.3.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2017-2028)
        7.3.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Eosinophilic Esophagitis Drug Market Size by Type
        8.1.1 Asia Pacific Eosinophilic Esophagitis Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Eosinophilic Esophagitis Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Eosinophilic Esophagitis Drug Market Size by Application
        8.2.1 Asia Pacific Eosinophilic Esophagitis Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Eosinophilic Esophagitis Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Eosinophilic Esophagitis Drug Market Size by Region
        8.3.1 Asia Pacific Eosinophilic Esophagitis Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Eosinophilic Esophagitis Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Eosinophilic Esophagitis Drug Market Size by Type
        9.1.1 Latin America Eosinophilic Esophagitis Drug Sales by Type (2017-2028)
        9.1.2 Latin America Eosinophilic Esophagitis Drug Revenue by Type (2017-2028)
    9.2 Latin America Eosinophilic Esophagitis Drug Market Size by Application
        9.2.1 Latin America Eosinophilic Esophagitis Drug Sales by Application (2017-2028)
        9.2.2 Latin America Eosinophilic Esophagitis Drug Revenue by Application (2017-2028)
    9.3 Latin America Eosinophilic Esophagitis Drug Market Size by Country
        9.3.1 Latin America Eosinophilic Esophagitis Drug Sales by Country (2017-2028)
        9.3.2 Latin America Eosinophilic Esophagitis Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Eosinophilic Esophagitis Drug Market Size by Type
        10.1.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Size by Application
        10.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Eosinophilic Esophagitis Drug Market Size by Country
        10.3.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Corporation Information
        11.1.2 AstraZeneca Overview
        11.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AstraZeneca Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AstraZeneca Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 Bayer
        11.3.1 Bayer Corporation Information
        11.3.2 Bayer Overview
        11.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bayer Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bayer Recent Developments
    11.4 Adare Pharmaceuticals
        11.4.1 Adare Pharmaceuticals Corporation Information
        11.4.2 Adare Pharmaceuticals Overview
        11.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Adare Pharmaceuticals Recent Developments
    11.5 DBV Technologies
        11.5.1 DBV Technologies Corporation Information
        11.5.2 DBV Technologies Overview
        11.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 DBV Technologies Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 DBV Technologies Recent Developments
    11.6 Dr. Falk Pharma
        11.6.1 Dr. Falk Pharma Corporation Information
        11.6.2 Dr. Falk Pharma Overview
        11.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Dr. Falk Pharma Recent Developments
    11.7 Quorum Innovations
        11.7.1 Quorum Innovations Corporation Information
        11.7.2 Quorum Innovations Overview
        11.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Quorum Innovations Recent Developments
    11.8 Takeda
        11.8.1 Takeda Corporation Information
        11.8.2 Takeda Overview
        11.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Takeda Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Takeda Recent Developments
    11.9 Calypso
        11.9.1 Calypso Corporation Information
        11.9.2 Calypso Overview
        11.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Calypso Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Calypso Recent Developments
    11.10 Celgene
        11.10.1 Celgene Corporation Information
        11.10.2 Celgene Overview
        11.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Celgene Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Celgene Recent Developments
    11.11 Regeneron
        11.11.1 Regeneron Corporation Information
        11.11.2 Regeneron Overview
        11.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Regeneron Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Regeneron Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Eosinophilic Esophagitis Drug Industry Chain Analysis
    12.2 Eosinophilic Esophagitis Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Eosinophilic Esophagitis Drug Production Mode & Process
    12.4 Eosinophilic Esophagitis Drug Sales and Marketing
        12.4.1 Eosinophilic Esophagitis Drug Sales Channels
        12.4.2 Eosinophilic Esophagitis Drug Distributors
    12.5 Eosinophilic Esophagitis Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Eosinophilic Esophagitis Drug Industry Trends
    13.2 Eosinophilic Esophagitis Drug Market Drivers
    13.3 Eosinophilic Esophagitis Drug Market Challenges
    13.4 Eosinophilic Esophagitis Drug Market Restraints
14 Key Findings in The Global Eosinophilic Esophagitis Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Budesonide
    Table 3. Major Manufacturers of Fluticasone
    Table 4. Major Manufacturers of Others
    Table 5. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Eosinophilic Esophagitis Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Eosinophilic Esophagitis Drug Sales by Region (2017-2022) & (K Units)
    Table 8. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2017-2022)
    Table 9. Global Eosinophilic Esophagitis Drug Sales by Region (2023-2028) & (K Units)
    Table 10. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2023-2028)
    Table 11. Global Eosinophilic Esophagitis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2017-2022)
    Table 13. Global Eosinophilic Esophagitis Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2023-2028)
    Table 15. Global Eosinophilic Esophagitis Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturers (2017-2022)
    Table 17. Global Eosinophilic Esophagitis Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Eosinophilic Esophagitis Drug Revenue Share by Manufacturers (2017-2022)
    Table 19. Eosinophilic Esophagitis Drug Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Eosinophilic Esophagitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2021)
    Table 22. Eosinophilic Esophagitis Drug Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Eosinophilic Esophagitis Drug Product Offered
    Table 24. Date of Manufacturers Enter into Eosinophilic Esophagitis Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Eosinophilic Esophagitis Drug Sales by Type (2017-2022) & (K Units)
    Table 27. Global Eosinophilic Esophagitis Drug Sales by Type (2023-2028) & (K Units)
    Table 28. Global Eosinophilic Esophagitis Drug Sales Share by Type (2017-2022)
    Table 29. Global Eosinophilic Esophagitis Drug Sales Share by Type (2023-2028)
    Table 30. Global Eosinophilic Esophagitis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Eosinophilic Esophagitis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2017-2022)
    Table 33. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2023-2028)
    Table 34. Eosinophilic Esophagitis Drug Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Eosinophilic Esophagitis Drug Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Eosinophilic Esophagitis Drug Sales by Application (2017-2022) & (K Units)
    Table 37. Global Eosinophilic Esophagitis Drug Sales by Application (2023-2028) & (K Units)
    Table 38. Global Eosinophilic Esophagitis Drug Sales Share by Application (2017-2022)
    Table 39. Global Eosinophilic Esophagitis Drug Sales Share by Application (2023-2028)
    Table 40. Global Eosinophilic Esophagitis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Eosinophilic Esophagitis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2017-2022)
    Table 43. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2023-2028)
    Table 44. Eosinophilic Esophagitis Drug Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Eosinophilic Esophagitis Drug Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Eosinophilic Esophagitis Drug Sales by Type (2017-2022) & (K Units)
    Table 47. North America Eosinophilic Esophagitis Drug Sales by Type (2023-2028) & (K Units)
    Table 48. North America Eosinophilic Esophagitis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Eosinophilic Esophagitis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Eosinophilic Esophagitis Drug Sales by Application (2017-2022) & (K Units)
    Table 51. North America Eosinophilic Esophagitis Drug Sales by Application (2023-2028) & (K Units)
    Table 52. North America Eosinophilic Esophagitis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Eosinophilic Esophagitis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Eosinophilic Esophagitis Drug Sales by Country (2017-2022) & (K Units)
    Table 55. North America Eosinophilic Esophagitis Drug Sales by Country (2023-2028) & (K Units)
    Table 56. North America Eosinophilic Esophagitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Eosinophilic Esophagitis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Eosinophilic Esophagitis Drug Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Eosinophilic Esophagitis Drug Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Eosinophilic Esophagitis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Eosinophilic Esophagitis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Eosinophilic Esophagitis Drug Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Eosinophilic Esophagitis Drug Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Eosinophilic Esophagitis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Eosinophilic Esophagitis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Eosinophilic Esophagitis Drug Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Eosinophilic Esophagitis Drug Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Eosinophilic Esophagitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Eosinophilic Esophagitis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Eosinophilic Esophagitis Drug Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Eosinophilic Esophagitis Drug Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Eosinophilic Esophagitis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Eosinophilic Esophagitis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Eosinophilic Esophagitis Drug Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Eosinophilic Esophagitis Drug Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Eosinophilic Esophagitis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Eosinophilic Esophagitis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Eosinophilic Esophagitis Drug Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Eosinophilic Esophagitis Drug Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Eosinophilic Esophagitis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Eosinophilic Esophagitis Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Eosinophilic Esophagitis Drug Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Eosinophilic Esophagitis Drug Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Eosinophilic Esophagitis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Eosinophilic Esophagitis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Eosinophilic Esophagitis Drug Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Eosinophilic Esophagitis Drug Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Eosinophilic Esophagitis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Eosinophilic Esophagitis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Eosinophilic Esophagitis Drug Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Eosinophilic Esophagitis Drug Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 106. AstraZeneca Corporation Information
    Table 107. AstraZeneca Description and Major Businesses
    Table 108. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. AstraZeneca Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. AstraZeneca Recent Developments
    Table 111. GSK Corporation Information
    Table 112. GSK Description and Major Businesses
    Table 113. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. GSK Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. GSK Recent Developments
    Table 116. Bayer Corporation Information
    Table 117. Bayer Description and Major Businesses
    Table 118. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Bayer Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Bayer Recent Developments
    Table 121. Adare Pharmaceuticals Corporation Information
    Table 122. Adare Pharmaceuticals Description and Major Businesses
    Table 123. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Adare Pharmaceuticals Recent Developments
    Table 126. DBV Technologies Corporation Information
    Table 127. DBV Technologies Description and Major Businesses
    Table 128. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. DBV Technologies Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. DBV Technologies Recent Developments
    Table 131. Dr. Falk Pharma Corporation Information
    Table 132. Dr. Falk Pharma Description and Major Businesses
    Table 133. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Dr. Falk Pharma Recent Developments
    Table 136. Quorum Innovations Corporation Information
    Table 137. Quorum Innovations Description and Major Businesses
    Table 138. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Quorum Innovations Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Quorum Innovations Recent Developments
    Table 141. Takeda Corporation Information
    Table 142. Takeda Description and Major Businesses
    Table 143. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Takeda Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Takeda Recent Developments
    Table 146. Calypso Corporation Information
    Table 147. Calypso Description and Major Businesses
    Table 148. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Calypso Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Calypso Recent Developments
    Table 151. Celgene Corporation Information
    Table 152. Celgene Description and Major Businesses
    Table 153. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Celgene Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Celgene Recent Developments
    Table 156. Regeneron Corporation Information
    Table 157. Regeneron Description and Major Businesses
    Table 158. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Regeneron Eosinophilic Esophagitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Regeneron Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Eosinophilic Esophagitis Drug Distributors List
    Table 164. Eosinophilic Esophagitis Drug Customers List
    Table 165. Eosinophilic Esophagitis Drug Market Trends
    Table 166. Eosinophilic Esophagitis Drug Market Drivers
    Table 167. Eosinophilic Esophagitis Drug Market Challenges
    Table 168. Eosinophilic Esophagitis Drug Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Eosinophilic Esophagitis Drug Product Picture
    Figure 3. Global Eosinophilic Esophagitis Drug Market Share by Type in 2021 & 2028
    Figure 3. Budesonide Product Picture
    Figure 4. Fluticasone Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Eosinophilic Esophagitis Drug Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Clinics
    Figure 9. Drugstore
    Figure 10. Eosinophilic Esophagitis Drug Report Years Considered
    Figure 11. Global Eosinophilic Esophagitis Drug Sales 2017-2028 (K Units)
    Figure 12. Global Eosinophilic Esophagitis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Eosinophilic Esophagitis Drug Revenue 2017-2028 (US$ Million)
    Figure 14. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2023-2028)
    Figure 17. North America Eosinophilic Esophagitis Drug Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Eosinophilic Esophagitis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Eosinophilic Esophagitis Drug Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Eosinophilic Esophagitis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Eosinophilic Esophagitis Drug Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Eosinophilic Esophagitis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Eosinophilic Esophagitis Drug Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Eosinophilic Esophagitis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Eosinophilic Esophagitis Drug Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Eosinophilic Esophagitis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Eosinophilic Esophagitis Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Eosinophilic Esophagitis Drug in the World: Market Share by Eosinophilic Esophagitis Drug Revenue in 2021
    Figure 29. Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2017-2028)
    Figure 31. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2017-2028)
    Figure 32. Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2017-2028)
    Figure 33. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2017-2028)
    Figure 34. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2017-2028)
    Figure 35. North America Eosinophilic Esophagitis Drug Revenue Market Share by Type (2017-2028)
    Figure 36. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2017-2028)
    Figure 37. North America Eosinophilic Esophagitis Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Eosinophilic Esophagitis Drug Sales Share by Country (2017-2028)
    Figure 39. North America Eosinophilic Esophagitis Drug Revenue Share by Country (2017-2028)
    Figure 40. U.S. Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2017-2028)
    Figure 43. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2017-2028)
    Figure 45. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Eosinophilic Esophagitis Drug Sales Share by Country (2017-2028)
    Figure 47. Europe Eosinophilic Esophagitis Drug Revenue Share by Country (2017-2028)
    Figure 48. Germany Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. France Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Eosinophilic Esophagitis Drug Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Eosinophilic Esophagitis Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Eosinophilic Esophagitis Drug Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Eosinophilic Esophagitis Drug Revenue Share by Region (2017-2028)
    Figure 59. China Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. India Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Eosinophilic Esophagitis Drug Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Eosinophilic Esophagitis Drug Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Eosinophilic Esophagitis Drug Sales Share by Country (2017-2028)
    Figure 74. Latin America Eosinophilic Esophagitis Drug Revenue Share by Country (2017-2028)
    Figure 75. Mexico Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Eosinophilic Esophagitis Drug Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Share by Country (2017-2028)
    Figure 84. Turkey Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Eosinophilic Esophagitis Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Eosinophilic Esophagitis Drug Value Chain
    Figure 88. Eosinophilic Esophagitis Drug Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
Frequently Asked Questions
Eosinophilic Esophagitis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Eosinophilic Esophagitis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Eosinophilic Esophagitis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aircraft Carpets

Aircraft Carpets market is segmented by Type and by Application. Players, stakeholders, and other ... Read More